Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus

Gastroenterology

Volumn 155, Issue 5, 2018, Pages 1325-1347.e3

  Leddin, Desmond ^a,b   Lieberman, David A ^c   Tse, Frances ^d   Barkun, Alan N ^e   Abou Setta, Ahmed M ^f   Marshall, John K ^d   Samadder, N Jewel ^g   Singh, Harminder ^f   Telford, Jennifer J ^h   Tinmouth, Jill ⁱ   Wilkinson, Anna N ^j   Leontiadis, Grigorios I ^d  

^a UNIVERSITY OF LIMERICK   (Ireland)

^b DALHOUSIE UNIVERSITY   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^j UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

Adenoma; Cancer; Colonoscopy; Colorectal; FOBT; Neoplasms; Polyp; Screening

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; FAMILY HISTORY; FIRST-DEGREE RELATIVE; HISTOLOGY; HUMAN; MEDICAL SOCIETY; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SECOND-DEGREE RELATIVE; ADENOMA; COLORECTAL TUMOR; CONSENSUS; EARLY CANCER DIAGNOSIS; GASTROENTEROLOGY; GENETICS; OCCULT BLOOD;

ADENOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; CONSENSUS; EARLY DETECTION OF CANCER; GASTROENTEROLOGY; HUMANS; OCCULT BLOOD; PRACTICE GUIDELINES AS TOPIC;

EID: 85055792921     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2018.08.017     Document Type: Article

References (111)

1. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2017. Available at: http://www.cancer.ca/∼/media/cancer.ca/CW/publications/Canadian%20Cancer%20Statistics/Canadian-Cancer-Statistics-2017-EN.pdf. Updated 2017. Accessed February 15, 2018.
2. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2014, based on November 2016 SEER data submission. National Cancer Institute. Available at: https://seer.cancer.gov/csr/1975_2014/. Updated 2017. Accessed February 15, 2018.
3. Henrikson, N.B., Webber, E.M., Goddard, K.A., et al. Family history and the natural history of colorectal cancer: systematic review. Genet Med 17 (2015), 702–712.
4. Gupta, S., Provenzale, D., Regenbogen, S.E., et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 3.2017. J Natl Compr Canc Netw 15 (2017), 1465–1475.
5. Brenner, H., Stock, C., Hoffmeister, M., Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ, 348, 2014, g2467.
6. Xirasagar, S., Li, Y.J., Hurley, T.G., et al. Colorectal cancer prevention by an optimized colonoscopy protocol in routine practice. Int J Cancer 136 (2015), E731–E742.
7. Tinmouth, J., Vella, E.T., Baxter, N.N., et al. Colorectal cancer screening in average risk populations: evidence summary. Can J Gastroenterol Hepatol, 2016, 2016, 2878149.
8. Singh, H., Bernstein, C.N., Samadder, J.N., et al. Screening rates for colorectal cancer in Canada: a cross-sectional study. CMAJ Open 3 (2015), E149–E157.
9. Centers for Disease Control and Prevention. Table 72. Use of colorectal tests or procedures among adults aged 50–75, by selected characteristics: United States, selected years 2000–2013. Available at: https://www.cdc.gov/nchs/data/hus/2015/072.pdf. Updated 2015. Accessed February 15, 2018.
10. Zlot, A.I., Silvey, K., Newell, N., et al. Family history of colorectal cancer: clinicians’ preventive recommendations and patient behavior. Prev Chronic Dis, 9, 2012, E21.
11. Taylor, D.P., Cannon-Albright, L.A., Sweeney, C., et al. Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med 13 (2011), 737–743.
12. Townsend, J.S., Steele, C.B., Richardson, L.C., et al. Health behaviors and cancer screening among Californians with a family history of cancer. Genet Med 15 (2013), 212–221.
13. Robertson, D.J., Lee, J.K., Boland, C.R., et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 112 (2017), 37–53.
14. Canadian Task Force on Preventive Health Care, Bacchus, C.M., Dunfield, L., et al. Recommendations on screening for colorectal cancer in primary care. CMAJ 188 (2016), 340–348.
15. US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D.C., et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315 (2016), 2564–2575.
16. Kahi, C.J., Boland, C.R., Dominitz, J.A., et al. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 111 (2016), 337–346 quiz 347.
17. Provenzale, D., Jasperson, K., Ahnen, D.J., et al. Colorectal cancer screening, v1.2015. J Natl Compr Canc Netw 13 (2015), 959–968 quiz 968.
18. Leddin, D.J., Enns, R., Hilsden, R., et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol 24 (2010), 705–714.
19. Qaseem, A., Denberg, T.D., Hopkins, R.H. Jr., et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 156 (2012), 378–386.
20. Rex, D.K., Johnson, D.A., Anderson, J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 104 (2009), 739–750.
21. European Colorectal Cancer Screening Guidelines Working G, von Karsa, L., Patnick, J., et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 45 (2013), 51–59.
22. Rex, D.K., Boland, C.R., Dominitz, J.A., et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 153 (2017), 307–323.
23. Syngal, S., Brand, R.E., Church, J.M., et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110 (2015), 223–262 quiz 263.
24. Giardiello, F.M., Allen, J.I., Axilbund, J.E., et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 147 (2014), 502–526.
25. Guyatt, G.H., Oxman, A.D., Vist, G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
26. Sultan, S., Falck-Ytter, Y., Inadomi, J.M., The AGA Institute process for developing clinical practice guidelines part one: grading the evidence. Clin Gastroenterol Hepatol 11 (2013), 329–332.
27. Bressler, B., Marshall, J.K., Bernstein, C.N., et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology 148 (2015), 1035–1058 e3.
28. Nguyen, G.C., Bernstein, C.N., Bitton, A., et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology 146 (2014), 835–848 e6.
29. Fallone, C.A., Chiba, N., van Zanten, S.V., et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 151 (2016), 51–69 e14.
30. Nguyen, G.C., Seow, C.H., Maxwell, C., et al. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 150 (2016), 734–757 e1.
31. Alonso-Coello, P., Schunemann, H.J., Moberg, J., et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction. BMJ, 353, 2016, i2016.
32. Guyatt, G.H., Oxman, A.D., Kunz, R., et al. Going from evidence to recommendations. BMJ 336 (2008), 1049–1051.
33. Johns, L.E., Houlston, R.S., A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96 (2001), 2992–3003.
34. Baglietto, L., Jenkins, M.A., Severi, G., et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 59 (2006), 114–124.
35. Butterworth, A.S., Higgins, J.P., Pharoah, P., Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 42 (2006), 216–227.
36. Johnson, C.M., Wei, C., Ensor, J.E., et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control 24 (2013), 1207–1222.
37. Lowery, J.T., Ahnen, D.J., Schroy, P.C. 3rd, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer 122 (2016), 2633–2645.
38. Graff, R.E., Moller, S., Passarelli, M.N., et al. Familial risk and heritability of colorectal cancer in the Nordic Twin Study of Cancer. Clin Gastroenterol Hepatol 15 (2017), 1256–1264.
39. Guyatt, G.H., Oxman, A.D., Sultan, S., et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 64 (2011), 1311–1316.
40. Taylor, D.P., Burt, R.W., Williams, M.S., et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 138 (2010), 877–885.
41. Samadder, N.J., Smith, K.R., Hanson, H., et al. Increased risk of colorectal cancer among family members of all ages, regardless of age of index case at diagnosis. Clin Gastroenterol Hepatol 13 (2015), 2305–2311 e1–e2.
42. Andrieu, N., Launoy, G., Guillois, R., et al. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut 53 (2004), 1322–1328.
43. Muto, T., Bussey, H.J., Morson, B.C., The evolution of cancer of the colon and rectum. Cancer 36 (1975), 2251–2270.
44. Eide, T.J., Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 38 (1986), 173–176.
45. Leddin, D., Enns, R., Hilsden, R., et al. Colorectal cancer surveillance after index colonoscopy: guidance from the Canadian Association of Gastroenterology. Can J Gastroenterol 27 (2013), 224–228.
46. Winawer, S.J., Zauber, A.G., O'Brien, M.J., et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328 (1993), 901–906.
47. Lieberman, D.A., Rex, D.K., Winawer, S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143 (2012), 844–857.
48. Heitman, S.J., Ronksley, P.E., Hilsden, R.J., et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 7 (2009), 1272–1278.
49. Lieberman, D., Moravec, M., Holub, J., et al. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology 135 (2008), 1100–1105.
50. Ng, S.C., Lau, J.Y., Chan, F.K., et al. Risk of advanced adenomas in siblings of individuals with advanced adenomas: a cross-sectional study. Gastroenterology 150 (2016), 608–616 quiz e16–e17.
51. Strum, W.B., Colorectal adenomas. N Engl J Med 374 (2016), 1065–1075.
52. Imperiale, T.F., Ransohoff, D.F., Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med 156 (2012), 703–709.
53. Nakama, H., Zhang, B., Fukazawa, K., et al. Family history of colorectal adenomatous polyps as a risk factor for colorectal cancer. Eur J Cancer 36 (2000), 2111–2114.
54. Cottet, V., Pariente, A., Nalet, B., et al. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 133 (2007), 1086–1092.
55. Tuohy, T.M., Rowe, K.G., Mineau, G.P., et al. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer 120 (2014), 35–42.
56. Kumaravel, V., Heald, B., Lopez, R., et al. Patients do not recall important details about polyps, required for colorectal cancer prevention. Clin Gastroenterol Hepatol 11 (2013), 543–547 e1–e2.
57. Schoen, R.E., Razzak, A., Yu, K.J., et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology 149 (2015), 1438–1445 e1.
58. Fuchs, C.S., Giovannucci, E.L., Colditz, G.A., et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331 (1994), 1669–1674.
59. Fitzpatrick-Lewis, D., Ali, M.U., Warren, R., et al. Screening for colorectal cancer: a systematic review and meta-analysis. Clin Colorectal Cancer 15 (2016), 298–313.
60. Tinmouth, J., Vella, E., Baxter, N., et al. Colorectal cancer screening in average risk populations: evidence summary. Can J Gastroenterol Hepatol, 2016, 2016, 2878149.
61. Holme, O., Schoen, R.E., Senore, C., et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ, 356, 2017, i6673.
62. Lieberman, D.A., Weiss, D.G., Bond, J.H., et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343 (2000), 162–168.
63. Strul, H., Kariv, R., Leshno, M., et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol 101 (2006), 255–262.
64. Samadder, N.J., Curtin, K., Tuohy, T.M., et al. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology 147 (2014), 814–821 e5 quiz e15–e16.
65. Quintero, E., Carrillo, M., Gimeno-Garcia, A.Z., et al. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology 147 (2014), 1021–1030 e1 quiz e16–e17.
66. Lin, J.S., Piper, M.A., Perdue, L.A., et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 315 (2016), 2576–2594.
67. Holme, O., Bretthauer, M., Fretheim, A., et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev, 2013, CD009259.
68. Pitkaniemi, J., Seppa, K., Hakama, M., et al. Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland. BMJ Open Gastroenterol, 2, 2015 e000034.
69. Katsoula, A., Paschos, P., Haidich, A.B., et al. Diagnostic accuracy of fecal immunochemical test in patients at increased risk for colorectal cancer: a meta-analysis. JAMA Intern Med 177 (2017), 1110–1118.
70. Dominitz, J.A., Robertson, D.J., Ahnen, D.J., et al. Colonoscopy vs fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM): rationale for study design. Am J Gastroenterol 112 (2017), 1736–1746.
71. Quintero, E., Castells, A., Bujanda, L., et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366 (2012), 697–706.
72. Lee, J.K., Liles, E.G., Bent, S., et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med, 160, 2014, 171.
73. Heitman, S.J., Hilsden, R.J., Au, F., et al. Colorectal cancer screening for average-risk North Americans: an economic evaluation. PLoS Med, 7, 2010 e1000370.
74. Mansfield, C., Tangka, F.K., Ekwueme, D.U., et al. Stated preference for cancer screening: a systematic review of the literature, 1990–2013. Prev Chronic Dis, 13, 2016, E27.
75. Marshall, D.A., Johnson, F.R., Phillips, K.A., et al. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health 10 (2007), 415–430.
76. Salkeld, G.P., Solomon, M.J., Short, L., et al. Measuring the importance of attributes that influence consumer attitudes to colorectal cancer screening. ANZ J Surg 73 (2003), 128–132.
77. Hol, L., de Bekker-Grob, E.W., van Dam, L., et al. Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer 102 (2010), 972–980.
78. Howard, K., Salkeld, G., Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer. Value Health 12 (2009), 354–363.
79. Marshall, D.A., Johnson, F.R., Kulin, N.A., et al. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ 18 (2009), 1420–1439.
80. van Dam, L., Hol, L., de Bekker-Grob, E.W., et al. What determines individuals’ preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 46 (2010), 150–159.
81. Nayaradou, M., Berchi, C., Dejardin, O., et al. Eliciting population preferences for mass colorectal cancer screening organization. Med Decis Making 30 (2010), 224–233.
82. Pignone, M.P., Brenner, A.T., Hawley, S., et al. Conjoint analysis versus rating and ranking for values elicitation and clarification in colorectal cancer screening. J Gen Intern Med 27 (2012), 45–50.
83. Hawley, S.T., Volk, R.J., Krishnamurthy, P., et al. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care 46:Suppl 1 (2008), S10–S16.
84. Shokar, N.K., Carlson, C.A., Weller, S.C., Informed decision making changes test preferences for colorectal cancer screening in a diverse population. Ann Fam Med 8 (2010), 141–150.
85. Dolan, J.G., Patient priorities in colorectal cancer screening decisions. Health Expect 8 (2005), 334–344.
86. Dolan, J.G., Boohaker, E., Allison, J., et al. Patients’ preferences and priorities regarding colorectal cancer screening. Med Decis Making 33 (2013), 59–70.
87. McLachlan, S.A., Clements, A., Austoker, J., Patients’ experiences and reported barriers to colonoscopy in the screening context—a systematic review of the literature. Patient Educ Couns 86 (2012), 137–146.
88. Ingrand, I., Defossez, G., Richer, J.P., et al. Colonoscopy uptake for high-risk individuals with a family history of colorectal neoplasia: a multicenter, randomized trial of tailored counseling versus standard information. Medicine (Baltimore), 95, 2016 e4303.
89. Pignone, M., Saha, S., Hoerger, T., et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002), 96–104.
90. Telford, J.J., Levy, A.R., Sambrook, J.C., et al. The cost-effectiveness of screening for colorectal cancer. CMAJ 182 (2010), 1307–1313.
91. Barzi, A., Lenz, H.J., Quinn, D.I., et al. Comparative effectiveness of screening strategies for colorectal cancer. Cancer 123 (2017), 1516–1527.
92. Sharaf, R.N., Ladabaum, U., Comparative effectiveness and cost-effectiveness of screening colonoscopy vs sigmoidoscopy and alternative strategies. Am J Gastroenterol 108 (2013), 120–132.
93. Ramsey, S.D., Wilschut, J., Boer, R., et al. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs. Am J Gastroenterol 105 (2010), 1861–1869.
94. Ouakrim, D.A., Boussioutas, A., Lockett, T., et al. Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC Cancer, 14, 2014, 261.
95. Wilschut, J.A., Steyerberg, E.W., van Leerdam, M.E., et al. How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?. Cancer 117 (2011), 4166–4174.
96. Ladabaum, U., Ferrandez, A., Lanas, A., Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev 19 (2010), 2765–2776.
97. Brenner, H., Haug, U., Arndt, V., et al. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 138 (2010), 870–876.
98. Brenner, H., Chang-Claude, J., Seiler, C.M., et al. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 29 (2011), 3761–3767.
99. Chen, C.D., Yen, M.F., Wang, W.M., et al. A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer 88 (2003), 1866–1873.
100. Martinez, M.E., Sampliner, R., Marshall, J.R., et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120 (2001), 1077–1083.
101. Samadder, N.J., Jasperson, K., Burt, R.W., Hereditary and common familial colorectal cancer: evidence for colorectal screening. Dig Dis Sci 60 (2015), 734–747.
102. Shaukat, A., Mongin, S.J., Geisser, M.S., et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 369 (2013), 1106–1114.
103. Mandel, J.S., Church, T.R., Bond, J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000), 1603–1607.
104. van Roon, A.H., Goede, S.L., van Ballegooijen, M., et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 62 (2013), 409–415.
105. Hennink, S.D., van der Meulen-de Jong, A.E., Wolterbeek, R., et al. Randomized comparison of surveillance intervals in familial colorectal cancer. J Clin Oncol 33 (2015), 4188–4193.
106. Nishihara, R., Wu, K., Lochhead, P., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
107. Schreuders, E.H., Ruco, A., Rabeneck, L., et al. Colorectal cancer screening: a global overview of existing programmes. Gut 64 (2015), 1637–1649.
108. de Vos tot Nederveen Cappel, W.H., Nagengast, F.M., Griffioen, G., et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 45 (2002), 1588–1594.
109. Mecklin, J.P., Aarnio, M., Laara, E., et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 133 (2007), 1093–1098.
110. Renkonen-Sinisalo, L., Aarnio, M., Mecklin, J.P., et al. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev 24 (2000), 137–142.
111. Bretthauer, M., Kaminski, M.F., Loberg, M., et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med 176 (2016), 894–902.